Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|May 10, 2026
Robot-Assisted Versus Open Bladder Cuff Excision After Radical Nephroureterectomy: A Multicenter Study by the French Urothelial Cancer CommitteePierre-Etienne Gabriel, Thomas Seisen, Evanguelos Xylinas, et al.
Cancer Immunology Research|June 8, 2026
ILT2 identifies an unexploited pool of intratumoral CD8+ bystander T cells with TCR-independent cytotoxicity in renal cell carcinomaRebecca Laboureur, Clément Dumont, Dzenis Koca, et al.
World Journal of Urology|March 31, 2015
The use of hemostatic agents does not prevent hemorrhagic complications of robotic partial nephrectomyBenoit Peyronnet, Emmanuel Oger, Zineddine Khene, et al.
Iscience|February 9, 2026
BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4<sup>+</sup> Th1 responsesPaul Rollin, Benjamin Pluskwa, Emilie Artru, et al.
European Urology Oncology|April 16, 2025
Challenges in Defining Clinical Complete Response to Systemic Therapy in Muscle-invasive Bladder Cancer: Insights from the EORTC STARBURST ProjectAlexandra Masson-Lecomte, Guillaume Grisay, Julien Van Damme, et al.
European Urology Oncology|November 19, 2024
Anatomic Factors Associated with Complications After Radical Prostatectomy: A Systematic Review and Meta-analysisArthur Peyrottes, Charles Dariane, Michael Baboudjian, et al.
Cancers|November 11, 2022
Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer CommitteeAlexandra Masson-Lecomte, Victoire Vaillant, Mathieu Roumiguié, et al.
Urologia Internationalis|April 6, 2017
Off-Clamp versus On-Clamp Robotic Partial Nephrectomy: A Multicenter Match-Paired Case-Control StudyBenoit Peyronnet, Zine-Eddine Khene, Benjamin Pradère, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2025
Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 TrialNadine Houédé, Thierry Chevallier, François Audenet, et al.
European Urology Oncology|June 24, 2026
Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer TrialsPietro Scilipoti, Aleksander Ślusarczyk, Constance Thibault, et al.
Pageof 10